Medpace Holdings, Inc. MEDP
3 trading plans running, 20 Form 144 notices for $365.0M
10-Q, 10-K and Form 144What MEDP's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Jul 24, 2025 to Feb 16, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Kevin M. Brady Chief Financial Officer and Treasurer |
Adopted other arrangement | Aug 20, 2026 | 10-Q Oct 22, 2026 |
| August J. Troendle Chief Executive Officer, President and Chairman of the Board |
Adopted other arrangement | Jul 27, 2026 | 10-Q Oct 22, 2026 |
| Susan E. Burwig Executive Vice President, Operations |
Adopted other arrangement | Jul 27, 2026 | 10-Q Oct 22, 2026 |
| Brad W. Hansman Executive Vice President, Operations |
Ended other arrangement | Jun 4, 2026 | 10-Q Jul 23, 2026 |
| Stephen P. Ewald General Counsel and Corporate Secretary |
Adopted other arrangement | Apr 27, 2026 | 10-Q Jul 23, 2026 |
| August J. Troendle Chief Executive Officer and Chairman of the Board |
Ended other arrangement | Dec 4, 2025 | 10-K Feb 10, 2026 |
| Susan E. Burwig Executive Vice President, Operations |
Adopted other arrangement | Nov 24, 2025 | 10-K Feb 10, 2026 |
| Kevin M. Brady Chief Financial Officer and Treasurer |
Adopted other arrangement | Nov 21, 2025 | 10-K Feb 10, 2026 |
| Jesse J. Geiger President |
Adopted 10b5-1 plan | Oct 27, 2025 | 10-K Feb 10, 2026 |
| Susan E. Burwig Executive Vice President, Operations |
Adopted other arrangement | Sep 3, 2025 | 10-Q Oct 23, 2025 |
| August J. Troendle Chief Executive Officer and Chairman of the Board |
Ended other arrangement | Aug 1, 2025 | 10-Q Oct 23, 2025 |
| Stephen P. Ewald General Counsel and Corporate Secretary |
Adopted other arrangement | Jul 28, 2025 | 10-Q Oct 23, 2025 |
| Jesse J. Geiger President |
Adopted 10b5-1 plan | Jul 24, 2025 | 10-Q Oct 23, 2025 |
| Kevin M. Brady Chief Financial Officer and Treasurer |
Adopted other arrangement | Jul 24, 2025 | 10-Q Oct 23, 2025 |
| Robert O. Kraft Director |
Adopted other arrangement | Aug 22, 2024 | 10-Q Oct 22, 2024 |
| Susan E. Burwig Executive Vice President, Operations |
Adopted other arrangement | Jun 5, 2024 | 10-Q Jul 23, 2024 |
| August J. Troendle Chief Executive Officer and Chairman of the Board |
Ended other arrangement | May 30, 2024 | 10-Q Jul 23, 2024 |
| Susan E. Burwig Executive Vice President, Operations |
Adopted other arrangement | Mar 15, 2024 | 10-Q Apr 23, 2024 |
| August J. Troendle Chief Executive Officer and Chairman of the Board of the Company |
Adopted other arrangement | Mar 7, 2024 | 10-Q Apr 23, 2024 |
| Jesse J. Geiger President |
Adopted other arrangement | Mar 4, 2024 | 10-Q Apr 23, 2024 |
| Ashley M. Keating Director |
Adopted other arrangement | Feb 26, 2024 | 10-Q Apr 23, 2024 |
| Susan E. Burwig Executive Vice President, Operations |
Adopted other arrangement | Dec 14, 2023 | 10-K Feb 13, 2024 |
| August J. Troendle Chief Executive Officer and Chairman of the Board of the Company |
Adopted other arrangement | Nov 29, 2023 | 10-K Feb 13, 2024 |
| August J. Troendle Chief Executive Officer and Chairman of the Board of the Company |
Ended 10b5-1 plan | Sep 21, 2023 | 10-Q Oct 24, 2023 |
| Kevin M. Brady Chief Financial Officer and Treasurer |
Adopted other arrangement | Jul 31, 2023 | 10-Q Oct 24, 2023 |
| Stephen P. Ewald General Counsel and Corporate Secretary |
Adopted other arrangement | Jul 26, 2023 | 10-Q Oct 24, 2023 |
| August J. Troendle Chief Executive Officer and Chairman of the Board of the Company |
Adopted 10b5-1 plan | May 1, 2023 | 10-Q Jul 25, 2023 |
Show the other 19 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 25, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 29, 2026 | EWALD STEPHEN P Officer |
1,245 | $859K |
| Oct 27, 2026 | BURWIG SUSAN E Officer |
3,940 | $2.7M |
| Oct 26, 2026 | BURWIG SUSAN E Officer |
16,060 | $10.9M |
| Aug 26, 2026 | Kraft Robert O. Director |
3,858 | $2.4M |
| Aug 20, 2026 | Brady Kevin M. Officer |
3,400 | $2.1M |
| Aug 19, 2026 | Carley Brian T Director |
5,000 | $3.0M |
| Aug 19, 2026 | DAVENPORT FRED B JR Director |
7,283 | $4.4M |
| Aug 11, 2026 | McCarthy Cornelius P. III Director |
1,140 | $690K |
| Aug 7, 2026 | McCarthy Cornelius P. III Director |
795 | $465K |
| Jul 29, 2026 | GEIGER JESSE J Former Officer |
11,000 | $7.0M |
| Jul 28, 2026 | BURWIG SUSAN E Officer |
7,500 | $4.5M |
| Jul 28, 2026 | GEIGER JESSE J Former Officer |
4,000 | $2.4M |
| Jul 27, 2026 | August J. Troendle Chairman |
307,959 | $184.8M |
| Jul 23, 2026 | GEIGER JESSE J Former Officer |
11,000 | $7.0M |
| May 28, 2026 | EWALD STEPHEN P Officer |
16,349 | $7.4M |
| Mar 17, 2026 | GEIGER JESSE J Officer |
31,707 | $14.5M |
| Nov 25, 2025 | August J. Troendle Chairman |
150,000 | $92.2M |
| Nov 24, 2025 | BURWIG SUSAN E Officer |
20,000 | $12.2M |
| Nov 21, 2025 | Brady Kevin M. Officer |
3,000 | $1.8M |
| Nov 14, 2025 | Kraft Robert O. Director |
6,472 | $3.8M |
Show the other 12 notices
From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MEDP/export.csv") into a cell.